PFE · Pfizer Inc · Documents

May 2

Current report 8-K

Financial results

May 2

Earnings call

Q1 2023 earnings call

May 1

Current report 8-K Events of Apr 27

Shareholder vote results

Apr 10

Proxy statement DEFA14A

Proxy statement

Apr 10

Proxy statement DEFA14A

Proxy statement

Mar 30

Proxy statement DEFA14A

Proxy statement

Mar 17

Annual report to holders ARS

Annual report to holders

Mar 16

Proxy statement DEF 14A

Proxy statement

Mar 16

Proxy statement DEFA14A

Proxy statement

Mar 13

Current report 8-K Events of Mar 12

Entered into a material agreement, Regulation FD disclosure, Other events

Feb 23

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $100.33B ▲ 23.4% Net income $31.37B ▲ 42.7% Diluted EPS $5.47 ▲ 42.1%

Feb 21

Current report 8-K

Other events

Jan 31

Earnings call

Q4 2022 earnings call

Jan 31

Current report 8-K

Financial results

Dec 13

Current report 8-K Events of Dec 9

Charter or bylaw amendment, or fiscal year change

Nov 9

Quarterly report 10-Q FY2022 Q3, ended Oct 2

Quarterly report for FY2022 Q3

Revenue $22.64B ▼ 5.8% Net income $8.61B ▲ 5.7% Diluted EPS $1.51 ▲ 6.3%

Nov 1

Current report 8-K

Financial results

Nov 1

Earnings call

Q3 2022 earnings call

Aug 10

Quarterly report 10-Q FY2022 Q2, ended Jul 3

Quarterly report for FY2022 Q2

Revenue $27.74B ▲ 46.8% Net income $9.91B ▲ 78.1% Diluted EPS $1.73 ▲ 76.5%

Jul 28

Earnings call

Q2 2022 earnings call

Jul 28

Current report 8-K

Financial results

May 11

Quarterly report 10-Q FY2022 Q1, ended Apr 3

Quarterly report for FY2022 Q1

Revenue $25.66B ▲ 76.8% Net income $7.86B ▲ 61.2% Diluted EPS $1.37 ▲ 59.3%

May 10

Current report 8-K Events of May 9

Regulation FD disclosure, Other events

May 3

Current report 8-K

Financial results

May 3

Earnings call

Q1 2022 earnings call

May 2

Current report 8-K Events of Apr 28

Shareholder vote results

Apr 22

Proxy statement DEFA14A

Proxy statement

Apr 20

Current report 8-K

Financial results

Apr 12

Current report 8-K Events of Apr 11

Director or officer change, or executive pay

Apr 11

Proxy statement DEFA14A

Proxy statement

Apr 6

Proxy statement DEFA14A

Proxy statement

Mar 30

Proxy statement DEFA14A

Proxy statement

Mar 29

Current report 8-K Events of Mar 24

Other events

Mar 17

Proxy statement DEF 14A Meeting Apr 28, 2022

Proxy statement

Mar 17

Proxy statement DEFA14A

Proxy statement

Feb 24

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $81.29B ▲ 95.2% Net income $21.98B ▲ 140.0% Diluted EPS $3.85 ▲ 136.2%

Feb 8

Earnings call

Q4 2021 earnings call

Feb 8

Current report 8-K

Financial results

Dec 15

Current report 8-K Events of Dec 9

Director or officer change, or executive pay

Nov 19

Current report 8-K Events of Nov 15

Director or officer change, or executive pay

Nov 12

Quarterly report 10-Q FY2021 Q3, ended Oct 3

Quarterly report for FY2021 Q3

Revenue $24.09B ▲ 134.4% Net income $8.15B ▲ 454.5% Diluted EPS $1.42 ▲ 446.2%

Nov 2

Earnings call

Q3 2021 earnings call

Nov 2

Current report 8-K

Financial results

Aug 18

Current report 8-K Events of Aug 16

Other events

Aug 12

Quarterly report 10-Q FY2021 Q2, ended Jul 4

Quarterly report for FY2021 Q2

Revenue $18.98B ▲ 92.4% Net income $5.56B ▲ 59.4% Diluted EPS $0.98 ▲ 58.1%

Jul 28

Current report 8-K

Financial results

Jul 28

Earnings call

Q2 2021 earnings call

Jul 9

Current report 8-K Events of Jul 6

Director or officer change, or executive pay

May 13

Quarterly report 10-Q FY2021 Q1, ended Apr 4

Quarterly report for FY2021 Q1

Revenue $14.58B ▲ 44.6% Net income $4.88B ▲ 45.4% Diluted EPS $0.86 ▲ 43.3%

May 4

Earnings call

Q1 2021 earnings call